[Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure].
Bezard
Erwan
E
UMR CNRS 5227, Mouvement-Adaptation-Cognition, 146, rue Léo Saignat, 33076 Bordeaux edex, France. erwan.bezard@u-bordeaux2.fr
D003342:Corpus Striatum / Q000187:drug effects / Q000503:physiopathology*; D004334:Drug Administration Schedule; D020820:Dyskinesias / Q000209:etiology*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology
D007980:Levodopa